HK1044003A1 - 共價寡聚膜破裂肽 - Google Patents

共價寡聚膜破裂肽

Info

Publication number
HK1044003A1
HK1044003A1 HK02103648.8A HK02103648A HK1044003A1 HK 1044003 A1 HK1044003 A1 HK 1044003A1 HK 02103648 A HK02103648 A HK 02103648A HK 1044003 A1 HK1044003 A1 HK 1044003A1
Authority
HK
Hong Kong
Prior art keywords
oligomerized
membrane disruptive
peptides covalently
disruptive peptides
covalently
Prior art date
Application number
HK02103648.8A
Other languages
English (en)
Inventor
Owen Phillips Ross
Hamilton Welsh John
Darphi Husain Rhonda
Original Assignee
Ml Laboratories Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9909567.1A external-priority patent/GB9909567D0/en
Priority claimed from GBGB9916912.0A external-priority patent/GB9916912D0/en
Priority claimed from GBGB9928303.8A external-priority patent/GB9928303D0/en
Application filed by Ml Laboratories Plc filed Critical Ml Laboratories Plc
Publication of HK1044003A1 publication Critical patent/HK1044003A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43572Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from bees
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723Cationic antimicrobial peptides, e.g. defensins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HK02103648.8A 1999-04-26 2002-05-14 共價寡聚膜破裂肽 HK1044003A1 (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9909567.1A GB9909567D0 (en) 1999-04-26 1999-04-26 A modified membrane disruptive peptide
US13237699P 1999-05-04 1999-05-04
GBGB9916912.0A GB9916912D0 (en) 1999-07-19 1999-07-19 A modified membrane disruptive peptide
GBGB9928303.8A GB9928303D0 (en) 1999-11-30 1999-11-30 A modified membrane disruptive peptide
PCT/GB2000/001588 WO2000064929A1 (en) 1999-04-26 2000-04-25 Membrane disruptive peptides covalently oligomerized

Publications (1)

Publication Number Publication Date
HK1044003A1 true HK1044003A1 (zh) 2002-10-04

Family

ID=27451899

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02103648.8A HK1044003A1 (zh) 1999-04-26 2002-05-14 共價寡聚膜破裂肽

Country Status (9)

Country Link
EP (1) EP1173474A1 (zh)
JP (1) JP2002544126A (zh)
KR (1) KR20020007382A (zh)
CN (1) CN1349543A (zh)
AU (1) AU4584800A (zh)
CA (1) CA2370284A1 (zh)
HK (1) HK1044003A1 (zh)
IL (1) IL145885A0 (zh)
WO (1) WO2000064929A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7446099B2 (en) 2004-02-27 2008-11-04 Nitto Denko Corporation Compositions and methods for biodegradable polymer-peptide mediated transfection
CN106589102A (zh) * 2016-11-30 2017-04-26 青岛大学 Orexin‑A聚乙二醇化修饰物制备及用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1010692C2 (nl) * 1998-12-01 2000-06-06 Stichting Tech Wetenschapp Antivirale peptiden.

Also Published As

Publication number Publication date
WO2000064929A1 (en) 2000-11-02
CA2370284A1 (en) 2000-11-02
AU4584800A (en) 2000-11-10
JP2002544126A (ja) 2002-12-24
CN1349543A (zh) 2002-05-15
KR20020007382A (ko) 2002-01-26
IL145885A0 (en) 2002-07-25
EP1173474A1 (en) 2002-01-23

Similar Documents

Publication Publication Date Title
AU6906800A (en) Membrane associated proteins
AU7358700A (en) Dolastatin peptides
IL146832A0 (en) Peptides
EP1173467A4 (en) CHEMOKIN DERIVED SYNTHETIC PEPTIDES
AU6223700A (en) Gtp-binding associated proteins
GB9918156D0 (en) Synthetic peptides
EP1185558A4 (en) PEPTIDES WITH PREPTID FUNCTIONALITY
GB9918155D0 (en) Proteins and peptides
EP1147130A4 (en) ALPHA-CONOTOXIN PEPTIDES
EP1159288A4 (en) ALPHA-CONOTOXIN PEPTIDES
IL145885A0 (en) Membrane disruptive peptides covalently oligomerized
GB9904695D0 (en) Peptide
GB9903408D0 (en) Peptides
AU3506800A (en) Leukocyte- and blood-associated proteins
AU3774000A (en) Conformationally constrained peptides
GB9908920D0 (en) Peptide
EP1151100A4 (en) PEPTIDES DESIGNED TAU-CONOTOXINS
HK1045173A1 (zh) 多肽
GB0202889D0 (en) Peptides (assay)
GB9909567D0 (en) A modified membrane disruptive peptide
GB9916912D0 (en) A modified membrane disruptive peptide
GB9928303D0 (en) A modified membrane disruptive peptide
GB9907911D0 (en) Peptides
GB9928325D0 (en) Peptides
GB9918680D0 (en) Polypeptide